Forward-Looking Statement
This page presents the legal notice, proprietary rights statement, and confidentiality terms applicable to PANOPTES and related Blink Pharma materials.
Published Consent Snapshot
This is the current visitor consent text managed from the PANOPTES admin interface.
Snapshot hash: 56ab00ffcbeea5fa4ed90e886a6c1f98326016eb25eb16eb27fa155bcdc5882f
This website, presentation, demonstration, and all related materials may contain forward-looking statements regarding the activities, products, services, strategies, technological developments, artificial intelligence capabilities, deployment roadmaps, interoperability, market opportunities, expected performance, operational objectives, partnerships, integrations, regulatory initiatives, financial projections, and future plans of Blink Pharma.
These statements are based on information, assumptions, estimates, expectations, and projections available as of the date of consultation. By their nature, forward-looking statements involve risks, uncertainties, technological changes, regulatory developments, market conditions, third-party dependencies, implementation challenges, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied.
Nothing contained in this website or associated materials shall be interpreted as:
Any demonstrations, prototypes, mockups, AI-generated content, workflows, visualizations, predictive models, dashboards, interfaces, simulations, or technical examples are provided solely for illustrative and informational purposes and may evolve, be modified, or be discontinued without prior notice.
Blink Pharma reserves the right to modify, suspend, replace, limit, or discontinue any product, service, feature, integration, architecture, or information presented at any time without obligation or liability.
Any reliance on the information contained herein is solely at the reader's own risk.
Intellectual Property and Proprietary Rights
All content accessible through this website, platform, demonstration, or presentation, including without limitation:
are and shall remain the exclusive property of Blink Pharma and/or its licensors, partners, suppliers, or affiliates.
No intellectual property rights, licenses, ownership rights, reproduction rights, exploitation rights, reverse-engineering rights, or commercial usage rights are granted by the mere consultation of these materials.
Any unauthorized:
whether partial or complete, is strictly prohibited without the prior written consent of Blink Pharma.
Certain elements presented may constitute:
Blink Pharma reserves all rights and may pursue any civil, commercial, contractual, administrative, or criminal remedies available under applicable law.
Mandatory Confidentiality Agreement Prior to Access
By accessing, browsing, reviewing, or interacting with this website, demonstration, platform, or related materials, the visitor expressly acknowledges and agrees that all information disclosed is confidential, proprietary, commercially sensitive, and protected.
The visitor agrees to the following terms:
1. Confidentiality Obligation
All information disclosed by Blink Pharma, whether oral, visual, written, electronic, technical, operational, commercial, or strategic, shall be treated as strictly confidential.
2. Permitted Purpose
The information may only be used for internal evaluation, partnership discussions, investment review, procurement assessment, or direct business discussions with Blink Pharma.
3. Non-Disclosure
The visitor shall not reproduce, distribute, disclose, transmit, publish, share, capture, store, display, circulate, or expose any part of the information to any third party without prior written authorization from Blink Pharma.
4. Non-Compete / Non-Reuse Restriction
The visitor agrees not to use any information obtained through this platform to develop competing products or services, replicate workflows or interfaces, train competing AI systems, reproduce concepts or methodologies, bypass technical mechanisms, conduct unauthorized competitive benchmarking, or perform reverse engineering activities.
5. Data Protection
The visitor acknowledges that certain information may relate to regulated healthcare, pharmaceutical, technical, operational, or commercially sensitive environments subject to legal and contractual obligations.
6. Duration
These confidentiality obligations shall remain in effect for a minimum period of five (5) years following the last access to the materials, unless a longer protection period applies under applicable law or separate agreement.
7. No Implied License
Nothing contained herein shall be interpreted as granting any implied license, ownership transfer, or intellectual property rights.
8. Governing Law
These terms shall be governed by and construed in accordance with the laws of the Kingdom of Morocco. Any dispute shall fall under the exclusive jurisdiction of the competent courts of Casablanca, unless otherwise agreed in writing.